Acute Pancreatitis Secondary to Ciprofloxacin Therapy in Patients with Infectious Colitis
분야
의약학 > 내과학
저자
안지원 , 이현정 , 성혜영 , 정대영 , 김진일 , 조세현 , 박수헌 , 한준열 , 김재광
발행기관
대한내과학회
간행물정보
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 56(총1쪽)
파일형식
42846262.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Ciprofloxacin is considered to be a safe and effective treatment of acute infectious colitis. However, this drug, albeit rarely, may cause drug-induced pancreatitis. This study was conducted to analyze the clinical features of pancreatitis caused by ciprofloxacin. Method: From January 2007 to March 2011, we registered 227 patients who were hospitalized infectious colitis at St. Mary`s hospital, Seoul, Korea. All the patients received ciprofloxacin therapy for a treatment of infectious colitis. We observed a few cases of rare adverse events; ciprofloxacin-induced acute pancreatitis diagnosed by the Naranjo algorithm. Results: During ciprofloxacin therapy, 7 of 227 patients (3.1%) were met rare adverse events (4 males and 3 females with a mean age of 46.9±17.4 years; range: 24-71). They were diagnosed to probable pancreatitis secondary to ciprofloxacin by the Naranjo algorithm; pancreatic enzyme was sporadically elevated with ciprofloxacin use. After ciprofloxacin administration, the average time interval until development of pancreatitis was 5.5 days (range: 4-7). In abdominal computed tomography, pancreatic swelling and homogenous enhancement was noted in 3 of 7 patients. Complicating acute pancreatitis was completely resolved gradually after the cessation of ciprofloxacin administration. Mean recovery time was 11.3 days (range: 8-15). Conclusion: We observed that ciprofloxacin-induced pancreatitis may occur with an incidence of approximately 3%. Drug-induced pancreatitis by ciprofloxacin displays a short latency, suggesting an idiosyncratic hypersensitivity reaction. If pancreatitis was detected early, the prognosis was very good. During ciprofloxacin use, practitioners should be aware that drug-induced pancreatitis can occur during ciprofloxacin therapy. And regular screening of chemical profiles is warranted.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.